Scenario.press - libera espressione Scenario.press - libera espressione
Результаты поиска
Все результаты
  • Вступить
    Войти
    Регистрация
    Поиск
    Ночной режим

Поиск

Знакомьтесь и заводите новых друзей

  • Новости
  • ИССЛЕДОВАТЬ
  • Страницы
  • Группы
  • Мероприятия
  • Reels
  • Статьи пользователей
  • Маркет
  • Funding
  • Offers
  • Jobs
  • Courses
  • Кинозал
  • Разработчики
  • Записей
  • Статьи пользователей
  • Пользователи
  • Страницы
  • Группы
  • Мероприятия
  • ahasanumi добавлена новая статья Другое
    2024-11-27 11:20:23 -
    PARP Inhibitors Market Size, Share, Growth and Forecast (2024-2032) | UnivDatos
    According to a new report by Univdatos Market Insights, PARP Inhibitors Market, is expected to reach USD 13835 Million in 2032 by growing at a CAGR of 12.9%. PARP (Poly (ADP-ribose) polymerase) inhibitors are a class of medications that interfere with the actions of PARP enzymes in cells. These enzymes are involved in DNA repair, particularly in the repair of single-strand DNA breaks. By...
    0 Комментарии 0 Поделились 4Кб Просмотры
    Войдите, чтобы отмечать, делиться и комментировать!
  • ahasanumi добавлена новая статья Другое
    2024-11-27 11:31:48 -
    PARP Inhibitors Market Size, Share, Growth and Forecast (2024-2032) | UnivDatos
    According to a new report by Univdatos Market Insights, PARP Inhibitors Market, is expected to reach USD 13835 Million in 2032 by growing at a CAGR of 12.9%. PARP (Poly (ADP-ribose) polymerase) inhibitors are a class of medications that interfere with the actions of PARP enzymes in cells. These enzymes are involved in DNA repair, particularly in the repair of single-strand DNA breaks. By...
    0 Комментарии 0 Поделились 4Кб Просмотры
    Войдите, чтобы отмечать, делиться и комментировать!
  • guptatanmayuds1308 добавлена новая статья Другое
    2025-06-19 06:54:34 -
    PARP Inhibitors Market Size, Share, Trends & Forecast to (2024-2032) | UnivDatos
    According to a new report by Univdatos, PARP Inhibitors Market, is expected to reach USD 13835 Million in 2032 by growing at a CAGR of 12.9%. The introduction of poly (ADP-ribose) polymerase (PARP) inhibitors have transformed the landscape of cancer treatment, particularly in the United States. These drugs have become a cornerstone in the management of various cancers, including ovarian,...
    0 Комментарии 0 Поделились 2Кб Просмотры
    Войдите, чтобы отмечать, делиться и комментировать!
  • CooL_PsD добавлена новая статья Networking
    2025-02-04 04:20:07 -
    Poly (ADP Ribose) Polymerase (PARP) Inhibitors Market To Register a Strong Growth Rate 2024 - 2031 |
    Poly (ADP Ribose) Polymerase (PARP) Inhibitors Market report has recently added by Analytic Insights Hub which helps to make informed business decisions. This research report further identifies the market segmentation along with their sub-types. Various factors are responsible for the market's growth, which are studied in detail in this research report. Poly (ADP Ribose) Polymerase (PARP)...
    0 Комментарии 0 Поделились 3Кб Просмотры
    Войдите, чтобы отмечать, делиться и комментировать!
© 2026 Scenario.press - libera espressione Russian
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About us Terms & Conditions Конфиденциальность Business Model Donations Свяжитесь с нами Каталог